Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Conformis Inc. CFMS

Conformis Inc is an us-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.


Recent & Breaking News (NDAQ:CFMS)

Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results

GlobeNewswire March 2, 2022

Conformis Suspends All Distribution Operations and Business Development in Russia

GlobeNewswire March 2, 2022

New Clinical Study Finds Bilateral Knee Patients Prefer Conformis' Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1

GlobeNewswire February 28, 2022

Conformis iTotal® CR Knee Replacement System Awarded "7A" Performance Rating from the U.K.'s Orthopaedic Data Evaluation Panel

GlobeNewswire February 24, 2022

Conformis, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire February 18, 2022

Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022

GlobeNewswire January 20, 2022

Conformis, Inc. Provides Business Update and Initial Expectations for 2022

GlobeNewswire January 6, 2022

Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022

GlobeNewswire January 4, 2022

Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary

GlobeNewswire December 23, 2021

Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported

GlobeNewswire November 8, 2021

Conformis Reports Third Quarter 2021 Financial Results

GlobeNewswire November 3, 2021

Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021

GlobeNewswire October 4, 2021

Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants

GlobeNewswire September 29, 2021

Conformis, Inc. Provides Business Update

GlobeNewswire September 20, 2021

Conformis, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire September 7, 2021

Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint(TM) Knee Replacement System

GlobeNewswire August 18, 2021

Conformis Reports Second Quarter 2021 Financial Results

GlobeNewswire August 4, 2021

Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

GlobeNewswire July 14, 2021

Conformis, Inc. Announces Settlement of Wright Medical Patent Litigation

GlobeNewswire July 7, 2021

Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021

GlobeNewswire July 1, 2021